Inhibitors

  

Why Choose Us

 

Rich experience
With decades of experience in researching, manufacturing and marketing organic chemicals, we have become a global supplier of chemical research, development and manufacturing.

 

Professional team
Genie Chemical has a highly skilled R&D team of more than 200 people.

 

One-stop service
Quality inspection, production control and after-sales service, providing one-stop service.

 

QC
It has obtained ISO 9001 certification and has set up a dedicated testing center to implement strict quality control standards at all stages of the production process. Quality inspectors closely monitor the production process of each product to ensure the quality of the final chemical product.

 

What is Inhibitors

 

 

An inhibitor (also known as a retarder) is a substance used to block or slow down the speed of a chemical reaction and has the same effect as a negative catalyst. It does not stop polymerization, it only slows it down. A substance used to inhibit or moderate chemical reactions.

 

First 123 Last 1/3

 

 
Benefits of Inhibitors
 

 

Treat ischemic disease

Tissue hypoxia is a common feature of ischemia, but activation of the HIF system occurs due to reduced supply and emission of metabolites, but the extent of this effect varies within and between ischemic tissues. HIF-PHD inhibitors increase HIF activity, thereby enhancing endogenous defense and repair responses. In models of cerebral ischemia, treatment before or immediately after arterial occlusion improves infarct volume assessment. A large number of ischemic protective mechanisms have been attributed to specific HIF target genes, including genes involved in reprogramming cellular metabolism, affecting apoptosis/survival pathways, and altering vascular permeability.

Improve inflammation

Inflammation is caused by multiple factors, including responses to pathogens, tissue damage, and immune dysregulation, and is an inherently progressive disease. The inflammation-induced high cytokine and chemokine environment and hypoxia jointly lead to the activation of HIFs, which in turn has multiple effects on immune and inflammatory cells, including differentiation, apoptosis, and effects on cytokine production. It has been reported that induction of HIF-1 activates pro-inflammatory Th17 T cells in various contexts by upregulating and coactivating the transcription factor ROR-γt and activating anti-inflammatory agents.

Neuroprotection

Exposure to mild hypoxia can have multiple health and medical benefits. Some athletes deprive themselves of oxygen intermittently to improve their endurance and performance. In medicine, exposure to mild hypoxia has positive effects on conditions ranging from chronic cardiopulmonary disease to iron deficiency and anemia, and neuroprotective effects have also been demonstrated. Luke Hunter has discovered two new inhibitors of moderate potency. These compounds show protective activity in neuroblastoma cells and have the potential to be developed as neuroprotective agents.

 

Types of Inhibitors
CAS:484-17-3 | 9-Phenanthrol
 

Competitive Inhibition

A molecule other than the substrate binds to the enzyme's active site, causing competitive inhibition. The inhibitor (molecule) has a structural and chemical similarity to the substrate (hence able to bind to the active site). The competitive inhibitor hinders substrate binding by blocking the active site. Since the inhibitor competes with the substrate, increasing the substrate concentration reduces the inhibitor's actions.

CAS:25118-59-6 | 4-Bromo-3-Chlorobenzoic Acid
 

Non-Competitive Inhibition

A chemical binds to a location other than the active site in non-competitive inhibition (an allosteric site). When the inhibitor binds to the allosteric site, the enzyme's active site undergoes a structural shift. The active site and substrate no longer share affinity as a result of this alteration, preventing the substrate from binding. Increased substrate levels will not be able to reverse the inhibitor's action since the inhibitor is not in direct competition with the substrate.

CAS:56396-35-1 | UK 5099
 

Uncompetitive Inhibition

The inhibitor binds only to the substrate-enzyme complex in uncompetitive inhibition. In reactions involving two or more substrates or products, uncompetitive inhibition is common. Non-competitive inhibition can occur with or without the presence of the substrate, whereas uncompetitive inhibition requires the formation of an enzyme-substrate complex.

 

Application of Inhibitors
 

Pharmaceutical and health care products industry

Inhibitors play a key role in the pharmaceutical and nutraceutical industries. An initial understanding of the action of inhibitors can help pharmacologists play a role in the design process of developing new therapeutics. Most drugs treat a variety of chronic and life-threatening diseases due to their specificity and potency of the enzymes they are able to inhibit. Enzyme inhibitors are used to screen for various levels of disease, leading to the development of inhibitors. The potential for enzyme inhibitors in the therapeutic market is very high due to the easy availability of biochemical properties and classes of enzyme inhibitor products.

Analytical sensors

Another broad aspect of inhibitors is their use in analytical sensors. These sensors help monitor various environmental factors. Understanding the mechanisms of enzyme inhibition and regeneration is a common problem faced by many biochemists and biotechnologists, especially when working with immobilized enzymes.

 

The Role of Inhibitors In Monomer Storage, Transport, Production, And Processing

 

Storage and transport inhibitors

During storage, monomers are usually not exposed to high temperatures, but are exposed to oxygen due to transfers, handling, and general opening and closing of containers. Therefore, an inhibitor that works best in the presence of oxygen is needed. During storage at room temperature, monomers are slowly forming free radicals (R•) on their own that, if left unchecked, can form polymers (RRRRRRRRR....). When oxygen is present, the monomer free radical reacts with oxygen to form a peroxide:

R• + O2 --> ROO•

This reaction is several orders of magnitude faster than R• self-polymerization. Therefore an inhibitor is needed that terminates the ROO• radical because ROO• outnumbers R• radicals in stored monomer by several orders of magnitude. Phenolic type inhibitors react very quickly with peroxide radical (ROO•) in a termination step.The phenolic inhibitors do not react with the monomer free radical (R•), thus oxygen is necessary for these inhibitors to function.

Production and processing inhibitors

During monomer production and processing, high temperatures are needed during reaction and/or distillation. Because of the high temperatures, monomers are quickly forming free radicals (R•) on their own which can lead to fast polymerization. In this high temperature environment, oxygen behaves mostly as an oxidant that oxidizes the monomer causing severe yellowing and tar formation. Therefore, to reduce product oxidation (yellowing and tar), oxygen must be excluded from high temperature processes. Since oxygen cannot be completely excluded, it will react with small amounts of R• to form ROO•. Therefore, an inhibitor system is required that can quench both R• and ROO• radicals. We have already discussed the phenolic inhibitors that can terminate ROO• radicals.

CAS:56396-35-1 | UK 5099

 

 
How to Choose Inhibitors
 
 
Chemistry

Structure should be defined, and its synthesis should be reproducible. Avoid common toxic moieties and pan-assay interfering moieties (PAINS). Likewise avoid chemically reactive groups, unless required such as for covalent addition stability icon Stability (purity and chemical identity) should be preserved in relevant media with attention made to any pH sensitivity. Activity should remain in culture media. The molecule shouldn’t exhibit non-specific chemical reactivity (e.g., redox reactions or membrane destabilization).

 
Potency

IC50 and Ki are the most common ways to denote inhibitor potency. In the context of enzyme inhibition, IC50 indicates the concentration of an inhibitor required to reduce the rate of an enzymatic reaction by 50% under the given experimental conditions. Ki denotes the ratio of inhibitor-target complex breakdown (koff) to inhibitor-target complex formation (kon) for the binding of the inhibitor to the enzyme. The term Ki is a thermodynamic equilibrium constant and is therefore a fixed value. IC50, on the other hand, is a representation of inhibition under a defined set of conditions and will change depending on factors such as the concentration of substrate present in the reaction setting. In the case of competitive inhibitors, IC50 can be related to Ki by the Cheng-Prusoff equation: IC50=Ki*(1+[S]0/Km). This is a useful web-based tool for converting IC50 values to Ki values using different inhibitor binding models.

 
Selectivity

Profiling will define the selectivity for related targets, which is often a more critical factor than potency. Typically, in biochemical assays, a factor of >10-100-fold in potency for the target against other family members defines an inhibitor as selective for that target. Inhibitors designed to be selective for your target of interest may still bind other proteins at higher concentrations. It is important to be aware of any additional activities associated with a particular chemical class.Negative control experiments can be designed to demonstrate that the inhibitor does not effectively alter the function of any off-target proteins at the concentration used to inhibit the desired target. Well-considered negative controls such as exposing cells or proteins only to the solvent or substituting closely related inactive structural analogs, such as R/S stereoisomers, help confirm the effect of the inhibitor.

 
Mechanism

Mechanism of action is important to further define the nature of the inhibitor in order to determine how natural substrates at physiologic concentrations will modulate inhibitor efficacy and to identify any vulnerabilities associated with this mechanism. Potential inhibition events include:The inhibitor binds the enzyme, often through covalent attachment, which irreversibly inactivates it. While irreversible inhibitors are typically covalent, non-covalent inhibitors can at times be so long lived that they act as irreversible inhibitors.

 

 

Process of Inhibitors

 

Raw material preparation

Before entering the production process, the required raw materials need to be prepared. Generally speaking, the raw materials used are alcohols, aliphatic acids, aromatic acids, aldehydes, ketones, carboxylic acids, esters, etc.

01

Reaction

The raw materials are added to the reactor and then heated to a suitable temperature, and the catalyst is added to start the reaction. Generally speaking, the reaction temperature is approximately between 150°C and 250°C.

02

Neutralize and purify

There are some unwanted impurities in the reaction product, which need to be removed through neutralization and purification steps. Usually acid-base neutralization method is used.

03

Washing separation

After neutralization and purification, the product needs to be separated by washing to remove water and impurities.

04

Filter and dry

By filtration and drying, the product is obtained in granular or powder form. After final quality inspection, qualified products can be packaged and sold.

05

 

 
Things to Note About Inhibitors
 
01/

Pay attention to how to take medicine
Inhibitors should be taken 1 hour before or 2 hours after meals to ensure optimal efficacy, and should be taken 2 times a day, 12 hours apart. If vomiting or diarrhea occurs after taking the medicine, please contact your doctor promptly to see if you need to take more medicine.

02/

Be aware of drug interactions
Other drugs may interact with inhibitors. If you need to use other drugs, be sure to consult your doctor in advance to avoid adding more drugs that may cause damage to liver and kidney function or cause changes in the blood concentration of immunosuppressant drugs.

03/

Pay attention to medicine storage
Inhibitors should be placed in the original box and stored in a dry, clean, cool, and dark place.

04/

Pay attention to buying
It is recommended to purchase inhibitors through formal channels to avoid purchasing inhibitors.

 

 
Our Factory
 

 

With decades of experience in manufacturing and marketing high-quality chemicals, Gnee Chemical Company, we supply Organic Chemicals, Biochemicals, Pharmaceutical Intermediates, and more.Gnee Chemical has a skilled workforce in research and development. Our team of more than 200 people is responsible for quality testing, production control and after-sales service as a one-stop service. We provide R&D and production solutions to our global customers.We adhere to the principle of "Quality First" and have obtained ISO 9001 certification. We have also set up a dedicated testing center to implement strict quality control standards at all stages of the production process. Quality inspectors closely monitor the production process of each product to ensure the quality of the final chemical products.

 

productcate-1-1

 

Certifications

 

productcate-1-1
productcate-1-1
productcate-1-1
productcate-1-1
productcate-1-1
productcate-1-1
 
 
FAQ
 
 

Q: What do factor Xa inhibitors do?

A: Factor Xa inhibitors are small molecules that selectively and reversibly bind to the active site of activated factor X (Xa), which blocks the interaction with its substrate in a rapid and competitive fashion, therefore inhibiting the final effects of thrombin generation.

Q: What are examples of direct thrombin inhibitors?

A: Currently, four parenteral direct inhibitors of thrombin activity are FDA-approved in North America: lepirudin, desirudin, bivalirudin and argatroban. Of the new oral DTIs, dabigatran etexilate is the most studied and promising of these agents.

Q: What factors do DOACs inhibit?

A: Direct Oral Anticoagulants (DOACs).Four agents inhibit factor Xa (apixaban, betrixaban, edoxaban, and rivaroxaban) and one inhibits thrombin (dabigatran).

Q: Are DOACs factor Xa inhibitors?

A: Direct oral anticoagulants (DOACs) are among the most commonly used anticoagulants in recent years. Among them, rivaroxaban, apixaban, and edoxaban achieve anticoagulation effects by directly inhibiting factor Xa (FXa) in the coagulation pathway.

Q: What are the side effects of direct factor XA inhibitors?

A: Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain. Other side effects may include stomach upset, dizziness, anemia or increased blood levels of liver enzymes.

Q: What is the major inhibitor of thrombin?

A: Antithrombin III is a major inhibitor of thrombin and augmentation of its inhibitory actions by heparin is the basis for the clinical uses of heparin. Recent clinical and experimental studies have demonstrated that another glycosaminoglycan, dermatan sulfate, is an effective antithrombotic drug.

Q: What happens when thrombin is inhibited?

A: Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation. Blood Coagul Fibrinolysis.Andexanet alfa is the first FDA-approved agent for the reversal of anticoagulation in patients treated with apixaban or rivaroxaban. This agent dramatically decreases the anti-factor Xa activity within two minutes of administration and it has received an accelerated approval from the FDA.

Q: Do factor Xa inhibitors require blood testing?

A: Factor Xa inhibitors are newer anticoagulants that offer some advantages over older ones. The biggest advantage is that people taking them don't need frequent blood tests. People take factor Xa inhibitors to prevent or treat blood clots. They can take them for days or months, depending on the situation.

Q: What are the advantages of direct thrombin inhibitors?

A: Direct Thrombin Inhibitors.Theoretical advantages of DTIs include activity against fibrin-bound thrombin, less nonspecific binding to proteins and platelets, lack of a requirement for a cofactor, an absence of natural inhibitors, and a wider therapeutic window.

Q: How do you reverse factor Xa inhibitors?

A: Andexanet alfa, the active substance of Ondexxya, is a recombinant protein that acts as a decoy for the direct oral FXa inhibitors apixaban and rivaroxaban in the blood. As a result, andexanet alfa neutralises the anticoagulant effect of these inhibitors.

Q: Do direct thrombin inhibitors require monitoring?

A: Ximelagatran is an oral form of direct thrombin inhibitor. After oral administration, ximelagatran is rapidly absorbed and converted to its active form, melagatran, which can also be administered subcutaneously. Ximelagatran or melagatran does not require routine coagulation monitoring.

Q: Is there an antidote for direct thrombin inhibitors?

A: You can reverse the effects of the oral (by mouth) anticoagulant, dabigatran, with a idarucizumab injection through an IV (intravenous, or through your vein). Direct thrombin inhibitors you get through an IV don't have an antidote. But stopping an infusion limits the drug's effects fairly quickly.

Q: Can direct thrombin inhibitors be reversed?

A: Unfortunately, no such reversal agent exists yet for direct Xa inhibitors, however, there is one currently being investigated in Phase 3b clinical trials called Andexanet alpha. It is a recombinant factor Xa molecule which acts as a decoy for the drug to bind to.

Q: What are the most common inhibitors of thrombin?

A: The direct thrombin inhibitors include hirudin, synthetic hirudin fragments (hirugen, lepirudin, and bivalirudin [Hirulog]), and low-molecular-weight inhibitors that react with the active site of thrombin (dabigatran and argatroban).

Q: Do factor Xa inhibitors affect thrombin time?

A: Synthetic direct inhibitors of factor Xa are capable of prolonging the global anticoagulant assay times in a concentration-dependent fashion. The relative degree of thrombin generation inhibition at an equivalent prolongation is not similar to the results observed with heparins and oral anticoagulant drugs.

Q: What is the difference between direct and indirect thrombin inhibitors?

A: Direct FXa inhibitors may directly bind to FXa, whereas indirect inhibitors are dependent on antithrombin. Direct inhibitors may bind free FXa and, in contrast to indirect inhibitors, FXa within the prothrombinase complex or within clots as well.

Q: What is the half life of XA inhibitors?

A: It binds approximately 50% of plasma proteins, with the rest remaining unbound in the plasma. It has an approximate half life of 10–14 hours. Metabolism of the drug is mainly through hydrolysis but the CYP3A4 system also has a minor contribution.Direct oral anticoagulants (DOACs) are among the most commonly used anticoagulants in recent years. Among them, rivaroxaban, apixaban, and edoxaban achieve anticoagulation effects by directly inhibiting factor Xa (FXa) in the coagulation pathway.

Q: What is the antidote for thrombin inhibitors?

A: You can reverse the effects of the oral (by mouth) anticoagulant, dabigatran, with a idarucizumab injection through an IV (intravenous, or through your vein). Direct thrombin inhibitors you get through an IV don't have an antidote. But stopping an infusion limits the drug's effects fairly quickly.The main disadvantages of the direct thrombin inhibitors are the lack of an antidote or readily available clinical monitoring.

Q: Do direct thrombin inhibitors dissolve clots?

A: Oral DTIs, as well as heparin, and differently from vitamin K antagonists, are able to inactivate both fluid-phase and membrane-bound thrombin, which reflects the ability to dissolve organized thrombi.Andexanet alfa, the active substance of Ondexxya, is a recombinant protein that acts as a decoy for the direct oral FXa inhibitors apixaban and rivaroxaban in the blood. As a result, andexanet alfa neutralises the anticoagulant effect of these inhibitors

Q: What is the most important thrombin inhibitor?

A: Like ximelagatran, dabigatran etexilate is an orally active double prodrug that is rapidly converted to dabigatran, a low-molecular weight molecule that acts as a specific, potent and reversible direct thrombin inhibitor. It is currently the most studied and promising of the oral direct thrombin inhibitors.

As one of the leading inhibitors manufacturers and suppliers in China, we warmly welcome you to wholesale cheap inhibitors for sale here from our factory. All chemical products are with high quality and competitive price.

4 2 Pyridyl benzaldehyde, M 2 3 Epoxypropoxy N N Bis 2 3 Epoxypropyl Aniline

whatsapp

Phone

E-mail

Inquiry

Bag